Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Discuss Index Tracked By  


  Track the *RXDLV Index  

Drug Delivery Stocks (*RXDLV)

  Drug Delivery Ideas       Drug Delivery Performance       Drug Delivery Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
VRX, APRI, BDSI
VRX, HSP, NKTR
None
VRX, ALKS, HSP
 
Index Description: Companies that focus on technology for delivering pharmaceuticals - pills, patches, sprayes and more are represented here
     
Today:
1-month:
All-time:
-2.2%
-1.9%
-8.7%
vs S&P 500:
vs S&P 500:
vs S&P 500:
-2.3%
-7.6%
-6.7%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$2.2B
14.1
0.0%
     
64 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 ACRX $3.25 -0.11 -3.3% 2,400 23% $66.2M - 85% -36% No Alerts/News
 ALKS $18.47 -0.41 -2.2% 572,679 56% $2.4B - 56% -8% No Alerts/News
 APRI $3.78 -0.88 -18.9% 2,327,978 953% $102.2M - 17% -38% 4 Alerts (2 News) - View
 BDSI $2.12 +0.01 +0.5% 60,269 13% $62.9M - 175% -48% No Alerts/News
 CBRX $0.81 -0.04 -4.1% 671,103 21% $73.3M - 27% -81% 1 Alert (1 News) - View
 DRRX $0.82 -0.03 -3.3% 198,024 36% $71.7M - 14% -78% No Alerts/News
 FLML $6.65 +0.07 +1.1% 79,805 32% $158.9M - 84% -10% No Alerts/News
 HSP $34.11 -0.64 -1.8% 2,281,653 124% $5.8B - 27% -42% No Alerts/News
 KV.A $2.61 -0.08 -3.0% 1,499,631 156% $166.4M - 230% -81% 1 Alert (0 News) - View
 NKTR $6.98 -0.23 -3.2% 853,803 63% $831.8M - 71% -38% No Alerts/News
 VRX $48.49 -1.08 -2.2% 2,292,233 111% $15.2B - 51% -15% No Alerts/News
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Apricus Biosciences Prices $20.0 Million Public Offering of Common Stock and Warrants
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 09, 09:29AM from (www.globenewswire.com)
SAN DIEGO, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 08, 04:03PM from (www.globenewswire.com)
SAN DIEGO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pomerantz Law Firm Reminds Shareholders of Columbia Laboratories, Inc. of Upcoming Deadline -- CBRX
CBRX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 08, 02:32PM from (www.globenewswire.com)
NEW YORK, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Shareholders of Columbia Laboratories, Inc. ("Columbia" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cancer Center, in Lawsuit, Says a Doctor Appropriated a Discovery
CELG  NKTR  AET  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - February 05, 04:10PM from (feeds.nytimes.com)
The president of Memorial Sloan-Kettering Cancer Center, Dr. Craig B. Thompson, is in a billion-dollar dispute with his former  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Apricus Biosciences Announces Acquisition of NitroMist(TM) Rights Outside North America
APRI  NVDL  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 03, 09:33AM from (www.globenewswire.com)
SAN DIEGO, Feb. 3, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amylin Pharmaceuticals Continues to Soar in Wake of Bydureon Approval
LLY  ALKS  AMLN  GS  JEF  DB  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - February 02, 01:49PM from (www.benzinga.com)
Last Friday, the FDA finally approved Bydureon, a once-weekly diabetes shot developed by Amylin Pharmaceuticals (NASDAQ:  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pomerantz Law Firm Has Filed a Class Action Against Columbia Laboratories Inc. -- CBRX
CBRX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 01, 05:50PM from (www.globenewswire.com)
NEW YORK, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP has filed a class action lawsuit against  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Technicians Looking for Very Bullish Signal
WEN  TNB  WWW  HAE  ABB  BCOM  ACRX  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - January 30, 04:46PM from (www.tickerspy.com)
Stocks traded lower on the day, but finished well off their lows. Disputes over austerity and Greece's debt restructuring  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alkermes, Amylin, Delta Air, US Airways: U.S. Equity Preview
DAL  LCC  ALKS  AMLN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - January 27, 06:02PM from (www.bloomberg.com)
Shares of the following companies may have unusual moves in U.S. trading on Jan. 30. Stock symbols are in parentheses, and prices are as of 5 p.m. in New York.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval
LLY  NVO  ALKS  AMLN  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - January 27, 05:34PM from (feeds.nytimes.com)
The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Small Breather Amid Strong Run
HAL  TWIN  CBRX  GDP  PETS  RIMM  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - January 23, 04:38PM from (www.tickerspy.com)
After a strong run last week, stocks took a small breather today, with the major market average ending around breakeven.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Closing Bell
HAL  PG  SR  TWIN  AMGN  CBRX  RIMG  SIRI  MFN  GDP  PETS  COP  GOOG  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 23, 04:08PM from (247wallst.com)
Equity markets opened slightly higher this morning but trailed off to negative territory in the late morning. By late afternoon,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Morning Movers
TWIN  CBRX  MFN  PETS  URG  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 23, 10:06AM from (247wallst.wordpress.com)
There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Columbia Labs Fails to Win US Panel's Backing for Preterm Birth Gel
CBRX  WPI  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - January 20, 04:02PM from (www.bloomberg.com)
Columbia Laboratories Inc. (CBRX) and Watson Pharmaceuticals Inc. (WPI) failed to win the backing of advisers to U.S. regulators  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Stock Making Buffett’s Pals at the Sequoia Fund Rich: Valeant Pharmaceuticals
LLY  MRK  TEVA  VRX  BRK.B  BRK.A  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - January 20, 10:43AM from (ycharts.com)
Big pharmaceutical companies keep shareholders happy with big dividends and the occasional revolutionary drug to keep earnings  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Buffett's Pals at Sequoia Fund Own Less Berkshire, But Find Plenty of Winning Stocks
GLW  IBM  FAST  TRMB  VRX  ORLY  BRK.B  MA  AAP  GOOG  BRK.A  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - January 19, 11:43AM from (ycharts.com)
The Sequoia Fund Inc. is one of the hottest on Wall Street now, with so many investors clamoring to get in that its managers  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Apricus Biosciences Retains Argot Partners as Investor Relations Firm
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 19, 08:00AM from (www.globenewswire.com)
SAN DIEGO, Jan. 19, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Salix Story Keeps Improving
FRX  PGNX  VRX  AZN  NKTR  SLXP  ENDP  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - January 18, 12:10PM from (stocks.investopedia.com)
Salix is a great candidate for growth investors.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
China Trumps Europe
FRX  WFC  CBRX  C  USU  PVX  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - January 17, 04:47PM from (www.tickerspy.com)
Despite the numerous EU sovereign debt downgrades that were officially announced after the market closed on Friday, stocks  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 31



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Drug Delivery Stocks Index (*RXDLV).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments